• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • COVID-19 Patient Resource Center
    • Clinical Trials
    • Search Clinical Trials
    • Patient Notification System
    • What is Clinical Research?
    • Volunteering for a Clinical Trial
    • Understanding Informed Consent
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Clinical Trial Listings
    • Market Research
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
    • eCFR and Guidances
  • White Papers
  • Trial Listings
  • Advertise
  • COVID-19
  • iConnect
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Benchmark Research wins ViE Award for best clinical trial site

Benchmark Research wins ViE Award for best clinical trial site

May 1, 2012
CenterWatch Staff

Benchmark Research’s Austin, Texas location was recognized as Best Clinical Trial Site at the 2012 Vaccine Industry Excellence (ViE) Awards, held during the Annual World Vaccine Congress.

Benchmark Research is a network of therapeutically diverse, dedicated, multi-therapeutic research centers that specializes in vaccine research. The panel of judges commended Benchmark Research Austin for exceeding enrollment timelines for all studies and for being the first site to complete enrollment in three of the seven trials within the judging period.

“Having two Benchmark Research sites considered for the inaugural Best Clinical Trial Site category is a testament to the efforts of the entire Benchmark team, not only those nominated sites. I am very proud of what each of our sites accomplished over the last year, and I'm especially honored to have Austin recognized as the top site in this category,” said Mark Lacy, co-founder and CEO of Benchmark Research.

“It is truly an honor for Benchmark Research to be recognized as Best Clinical Trial Site. We have committed substantial time and resources in developing our specialty as industry-leading vaccine sites, and being recognized with this ViE award represents a culmination of those efforts,” added Scott Barrett, Benchmark Research co-founder and COO.

Benchmark Research offers clients access to nearly 60,000 patients in its research database and nearly 16 million potential patients in Sacramento and San Francisco, California; New Orleans, Louisiana; and Austin, Fort Worth and San Angelo, Texas. Benchmark’s geographic and demographic diversity allows it to meet and exceed enrollment projections. Currently, Benchmark works with more than 40 Principal Investigators and supports a range of therapeutic areas.

Upcoming Events

  • 16Feb

    Fundamentals of FDA Inspection Management: Reduce Anxiety, Increase Inspection Success

  • 21May

    WCG MAGI Clinical Research Conference – 2023 East

Featured Products

  • Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

    Spreadsheet Validation: Tools and Techniques to Make Data in Excel Compliant

  • Surviving an FDA GCP Inspection

    Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

Featured Stories

  • SurveywBlueBackground-360x240.png

    Sites Name Tech Acceptance as Essential Factor in Selection of Sponsors, Survey Finds

  • TrendsInsights2023-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Two

  • TimeMoneyEffort-360x240.png

    Time is Money and So Is Effort, Budgeting Experts Say

  • TrendsInsights2023A-360x240.png

    WCG Clinical Research Trends and Insights for 2023, Part Three

Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

The information you need to adapt your monitoring plan to changing times.

Learn More Here
  • About Us
  • Contact Us
  • Privacy Policy
  • Do Not Sell or Share My Data

Footer Logo

300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

Phone 617.948.5100 – Toll free 866.219.3440

Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing